MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus.
about
Clinical Evaluation of a Skin Protectant for the Management of Incontinence-Associated Dermatitis: An Open-Label, Nonrandomized, Prospective Study.The Skin Safety Model: Reconceptualizing Skin Vulnerability in Older Patients.PROTECT - trial: a multicentre prospective pragmatic RCT and health economic analysis of the effect of tailored repositioning to prevent pressure ulcers - study protocol.Candida albicans colonisation, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study.Incontinence-associated dermatitis: new insights into an old problem.Incontinence-associated dermatitis: identification, prevention and care.Risk Factors for Chronic Intertrigo of the Lymphedema Leg in Southern India: A Case-Control Study.Evaluation of a skin barrier cream for managing IAD in elderly patients using high-frequency ultrasound.Differential diagnosis of suspected deep tissue injury.Incontinence-associated dermatitis: a cross-sectional prevalence study in the Australian acute care hospital setting.Management of Moisture-Associated Skin Damage: A Scoping Review.Prevention and management of incontinence-associated dermatitis.Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options.Incontinence-associated dermatitis in the critically ill patient: an intensive care perspective.Classification of dependence-related skin lesions: a new proposal.Prevention and management of incontinence-associated dermatitis using a barrier cream.Incidence and Predictors of Incontinence-Associated Skin Damage in Nursing Home Residents With New-Onset Incontinence.A laboratory comparison between two liquid skin barrier products.
P2860
Q37691391-76E97AFD-880B-4425-B4F4-827B356F0E1CQ38637203-B9C5419F-3B87-47A5-9112-EE42DFC6FBEFQ39341931-969AEB0A-627B-447E-898F-B59224EA89D9Q39539450-6EDF4AA7-96B9-4F87-B812-9F7EE4C6DAF8Q40757165-C432EC8A-0626-49AD-A226-EB9F969CD963Q41228018-2039FE98-4D10-4A77-9823-DD2B575706DEQ41383461-ACBCB6B3-B338-4CB8-9C10-EE5ED062BF0CQ41726803-7CDEE583-625B-4DDB-AC1B-4B36913A8E03Q45015633-ED165155-0CC4-4C3E-8998-745F8C008740Q45120441-0B5EB45E-379B-4695-8DA1-E95FBE8E2C51Q47112526-5DF2E07D-3485-4A95-94E7-B9AC27F5C6E4Q47220747-37B38A3C-3A98-4958-8410-25848F0018E1Q48113785-F02AA0F4-EADF-4344-B90F-343B2050FE6AQ48367420-CADDD1F6-D8A6-43BF-AEDF-D9109747F6E6Q50892495-F8046F4E-0D01-4BC7-9D2D-CC39C580FDC8Q53368269-6834B9D0-69A7-42DA-8107-392C757B79C2Q53458920-C25382E8-615F-455E-82C2-D4C64B16D165Q53497666-BC0ECD19-BBA5-4228-AB22-100C81960E2C
P2860
MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MASD part 2: incontinence-asso ...... inous dermatitis: a consensus.
@en
MASD part 2: incontinence-asso ...... inous dermatitis: a consensus.
@nl
type
label
MASD part 2: incontinence-asso ...... inous dermatitis: a consensus.
@en
MASD part 2: incontinence-asso ...... inous dermatitis: a consensus.
@nl
prefLabel
MASD part 2: incontinence-asso ...... inous dermatitis: a consensus.
@en
MASD part 2: incontinence-asso ...... inous dermatitis: a consensus.
@nl
P2093
P1476
MASD part 2: incontinence-asso ...... inous dermatitis: a consensus.
@en
P2093
Catherine R Ratliff
Donna Z Bliss
Janice C Colwell
Joyce M Black
Karen L Kennedy-Evans
Margaret Goldberg
Mikel Gray
Mona M Baharestani
Susan Logan
P304
359-70; quiz 371-2
P356
10.1097/WON.0B013E31822272D9
P577
2011-07-01T00:00:00Z